<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20230731058990N3</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2024-02-01</date_registration>
      <primary_sponsor>UOL, Lahore</primary_sponsor>
      <public_title>Myofascial release and ergon technique effects in plantar fasciitis for foot function and balance</public_title>
      <acronym></acronym>
      <scientific_title>Effects of myofascial release and ergon technique on foot function and balance in plantar fasciitis</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2023-10-04</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>26</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/74900</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Heel pain, Windlass test, Berg Balance Scale, Foot Function Index, Randomization description: Participants were randomized using gold fish bowl method into two groups, control and experimental. Treatment allocation were done by using concealed envelope method. In this, sealed opaque envelops with treatment regimen written were provided to the participants. Once a patient had consented to enter a trial room, an envelope was opened, and the patient was then offered the allocated treatment, Blinding description: The study was single blinded. The participants did not know while they were receiving experimental or routine physical therapy treatment. and yes, intervention is similar enough for blinding participants.</study_design>
      <phase>3</phase>
      <hc_freetext>Plantar fasciitis.</hc_freetext>
      <i_freetext>Intervention 1: Group A received routine physical therapy included ultrasound. Ultrasound will be used for 10 minutes (Frequency 3MHz) in each session. Total duration for each session with intervention will be 25-30 minutes. After baseline treatment, myofascial release technique was given according to the anatomy trains concept on the superficial back line of lower limb. The subjects are taken in supine position with Lower Limb extended and foot in Dorsiflexion. Myofascial release technique was given on the plantar surface. The technique was performed in three strokes directly over the patient’s skin by sliding the hand throughout the Dorsiflexion with constant pressure in the caudo-cranial direction. Intervention 2: Group B received routine physical therapy included ultrasound. Ultrasound will be used for 10 minutes (Frequency 3MHz) in each session. Total duration for each session with intervention will be 25-30 minutes. After baseline treatment, Ergon technique has several different options for tools as well as treatment techniques. Now we use Graston tool while patient in prone position scan the tissue and point of fibrosis or any sort of restriction in gastrocnemius. Use the tool all the way down in sweeping motions feelings for restrictions from proximal to distal and from up to down at the junction of Achilles. Now ask the patient to do dorsiflexion while scooping Achilles tendon from insertion to origin.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Demographic data and data related to final outcome will be shared by maintaining the confidentiality.

When:
Data will be available from April 2024 to June 2024 after the 6 months of publication. The data sharing plan for a clinical trial (i.e., what data will be shared when and under what conditions) will be publicly available at a third-party site that shares data with and meets the data requirements of WHO's International Clinical Trials Registry Platform; this occur before the first participant is enrolled.

To whom:
Dr. Sania Naz (corresponding author) professor at UOL, Lahore.

Conditions:
for research purpose

Where to obtain:
To the corresponding author of the study, Dr Sania Naz and can contact on +923044407035 saaniaanaz@gmail.com can visit these search engines, you can find my study easily here https://www.researchgate.net/ https://scholar.google.com/

How to obtain:
Open-access and there is the traditional public data release where anyone can get access to the data with no registration or conditions. The request will be reviewed by Director in Charge and in case of eligibility, it would be shared in two weeks

Comments:
I want randomized clinical trial registration.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Sania Naz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-Km defense road Lahore, Pakistan</address>
        <city>Lahore</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 304 4407035</telephone>
        <email>sania.naz642@gmail.com</email>
        <affiliation>UOL, Lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Dr Kashaf Faraz</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>1-Km defense road Lahore, Pakistan</address>
        <city>Layyah</city>
        <country1>Pakistan</country1>
        <zip>54000</zip>
        <telephone>+92 304 6541357</telephone>
        <email>kashaffraz@gmail.com</email>
        <affiliation>UOL, Lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Age 30-50 years
Both Gender
Positive Windlass test
Pain in the morning when taking the first steps or after prolonged rest
Having unilateral resistant heel pain</inclusion_criteria>
      <agemin>30 years</agemin>
      <agemax>50 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Individuals with a history of trauma
A fracture below the knee during the preceding year
Any systemic illness, like rheumatism, arthritis
Prior foot surgery
A positive diagnosis of fat pad syndrome or tarsal tunnel syndrome were excluded</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>Plantar fa</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>M72.2</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Rehabilitation</i_code>
      <i_code>Rehabilitation</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Group A received routine physical therapy included ultrasound. Ultrasound will be used for 10 minutes (Frequency 3MHz) in each session. Total duration for each session with intervention will be 25-30 minutes. After baseline treatment, myofascial release technique was given according to the anatomy trains concept on the superficial back line of lower limb. The subjects are taken in supine position with Lower Limb extended and foot in Dorsiflexion. Myofascial release technique was given on the plantar surface. The technique was performed in three strokes directly over the patient’s skin by sliding the hand throughout the Dorsiflexion with constant pressure in the caudo-cranial direction</i_keyword>
      <i_keyword>Group B received routine physical therapy included ultrasound. Ultrasound will be used for 10 minutes (Frequency 3MHz) in each session. Total duration for each session with intervention will be 25-30 minutes. After baseline treatment, Ergon technique has several different options for tools as well as treatment techniques. Now we use Graston tool while patient in prone position scan the tissue and point of fibrosis or any sort of restriction in gastrocnemius. Use the tool all the way down in sweeping motions feelings for restrictions from proximal to distal and from up to down at the junction of Achilles. Now ask the patient to do dorsiflexion while scooping Achilles tendon from insertion to origin.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Foot Function. Timepoint: Baseline, 3rd week and 6th week of treatment. Method of measurement: Foot Function Index.</prim_outcome>
      <prim_outcome>Balance. Timepoint: Baseline, 3rd week and 6th week of treatment. Method of measurement: Berg Balance Scale.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Quality of Life. Timepoint: Baseline, 3rd and 6th week of treatment. Method of measurement: Short Form-12.</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>UOL, Lahore</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2023-08-12</approval_date>
        <contact_name>Research Ethics Committee (REC)</contact_name>
        <contact_address>1-Km defense road Lahore, Pakistan Lahore Punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
